MAX and gastric cancer: miR-19a and miR-19b are also upregulated in GC samples, and directly target MXD1 (MAX Dimerization Protein 1), an important molecule that competes with MYC for MAX (Myc-Associated factor X) binding, impairing the oncogenic MYC-MAX-MXD1 network [140].